Glow – TB-500 10mg / BPC-157 10mg / GHK-Cu 50mg

 169,00

Glow 70 mg – BPC-157 + GHK-Cu + TB-500 – Grail Formula Quality — researched and verified with Liquilabs s.r.o. Czechia. Analytical testing confirms BPC-157 assay 12.25 mg GHK-Cu assay 51.2 mg TB-500 assay 10.13 mg purity above 99.8 percent for all components RT identification 0.999 for BPC-157 and GHK-Cu 0.994 for TB-500 spectrum identifications 995 997 and 991 endotoxin below 0.001 EU per mg and no detectable heavy metals or microbial contamination. Supplied as a 70 mg multi-peptide lyophilized blend with full COA traceability. Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Glow 70 mg is a multi-component research peptide blend combining BPC-157, GHK-Cu and TB-500 in a single lyophilized vial. This formula supports controlled laboratory evaluation of tissue-modelling pathways, repair-associated biochemical signalling and copper-dependent peptide interactions. Analytical verification confirms assay values, purity and identity for each of the three components.   Peptide Overview From 2015 to 2025 research groups increasingly explored combined peptide models that unify regenerative, copper-binding and repair-modulating mechanisms. BPC-157 is studied for cellular-repair signalling, GHK-Cu for extracellular-matrix and copper-dependent pathways, and TB-500 for actin-modulating biochemical behaviour. This blend allows comparative and multi-factorial modelling under well-defined laboratory conditions.   Historical Background and Scientific Context Regenerative peptide research expanded significantly between 2014 and 2025, with interest rising in multi-peptide systems capable of modelling complex tissue-interaction pathways. Glow 70 mg reflects this direction by combining three well-characterised peptides into one analytical profile, enabling multi-pathway response evaluation and reproducible biochemical modelling.   Mechanistic Focus in Research
  • Regenerative and repair-pathway modelling
  • Copper-dependent biochemical interactions
  • Extracellular-matrix and actin-related studies
  • Comparative evaluation of multi-peptide systems
  • In-vitro modelling under controlled experimental conditions
  Analytical Verification (COA) Independent Liquilabs analysis confirms full analytical validation for Batch GF082025011. Key results include:
  • BPC-157 Spectrum Identification: 995
  • BPC-157 Assay: 12.25 mg
  • BPC-157 Retention Time: 0.999
  • BPC-157 Purity: above 99.8 percent
  • GHK-Cu Assay: 51.2 mg
  • GHK-Cu Retention Time: 0.999
  • GHK-Cu Spectrum Identification: 997
  • GHK-Cu Purity: above 99.8 percent
  • TB-500 Assay: 10.13 mg
  • TB-500 Retention Time: 0.994
  • TB-500 Spectrum Identification: 991
  • TB-500 Purity: above 99.8 percent
  • Endotoxins: below 0.001 EU per mg
  • Microbial Growth: not detected for aerobic count yeast or mold
  • Heavy Metals: not detected including arsenic cadmium lead nickel cobalt vanadium mercury
All analytical values originate from validated chromatographic, spectroscopic and microbiological procedures ensuring transparency and full traceability.   Research Applications
  • Multi-pathway regenerative modelling
  • Copper-dependent signalling studies
  • Tissue-repair and extracellular-matrix research
  • Comparative peptide-interaction analysis
  • In-vitro modelling of combined biochemical responses
 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use
  • Verified and analysed with Liquilabs s.r.o. Czechia
  • Above 99.8 percent purity for all three peptides
  • No detectable heavy metals or microbial contamination
  • Endotoxin below 0.001 EU per mg
  • Batch GF082025011 – Published September 2025
  • EU shipments include bacteriostatic water
  • For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products